Screener
Acadia Pharmaceuticals ACAD Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's net debt?
- Acadia Pharmaceuticals (ACAD) reported net debt of -$311.13M in Q2 2026.
- How has Acadia Pharmaceuticals's net debt changed year-over-year?
- Acadia Pharmaceuticals's net debt decreased by 57.7% year-over-year, from -$197.34M to -$311.13M.
- What is the long-term trend for Acadia Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's net debt has grown at a -14.6% compound annual growth rate (CAGR), from -$276.48M to -$125.51M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Acadia Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude